GENERAL COMMENTS
I think that this study has the potential to contribute greatly to the literature on access to HIV care for transgender persons, who are overrepresented within the global HIV epidemic and underresearched with respect to their access to care. I appreciate the authors' use of theory and methodological advancements, but believe the theory and methods have overshadowed some of the needed detail of the content and the importance of the study. I make some suggestions for where the authors can clarify the importance of their study.
Abstract -please provide an example of what you mean by diverse transgender populations -across which axes of diversity will you be looking? -will you include any study that has trans participants (including those not specific to trans people such as those pertaining to people living with HIV that include trans people), if yes, how will you decide which data to include, if no, please justify -I think there may be a typo -"apply in inclusion" should read "apply inclusion"? -you specify tools for mixed methods appraisal and text, opinion, and non-research studies -by text do you mean qualitative? If not, how will you assess quality of the qualitative studies (e.g., COREQ 32-item checklist). Please specify.
-can you add a line at the end of methods and analysis about the implications of these study findings (e.g., why is this study important, who will the results be important for, what will they inform) -please add an example of the peer-reviewed journal you will seek to publish in OR type of journal (e.g., LGBT health journal, HIV/AIDS journal)
Strengths and limitations of the study -overall, these could be strengthened by highlighting the importance of the study that you are exploring (trans peoples' engagement in HIV care, not only the strength of using theory and your particular methodology)
Background/introduction -the first sentence requires a reference -I am unclear what the difference is between awareness of HIV (which requires an HIV diagnosis) and HIV testing; similarly I'm unsure of the difference between early HIV care and HIV linkageand by long-term care do you mean retention? Please clarify.
-I am unclear about the meaning of the first sentence under 1.1. -is there another way to say this? -the second sentence also seems to be missing something? -similarly is there another way to say this? -finally the last sentence of that first paragraph mixes different types of healthcare access with barriers? -in the second paragraph under 1.1, can you please define systematic and felt stigma -the last sentence isn't complete? Do you mean that resurging anti-homosexuality laws and policies that threaten LGBT populations' access to health services perpetuates stigma and discrimination? Is because of stigma and discrimination? Please clarify.
-it would be helpful to state that life chances are unequally structured and limit personal agency -agency should be defined within the context of healthcare access -transwomen of colour should be trans women (with a space), similarly trans men -please change throughout -great rationale for why review studies are usefully applied and why theory is important -if reflecting on structuring mechanisms of race, social class, age, HIV status, have the authors considered mentioning intersectionality theory explicitly, as they have references from intersectionality theorists?
Methods -under objectives 2.1 -generally the term transgenders is not used -it would be akin to saying "gays" it is more common to use transgender persons (please fix throughout) -I'm not sure if constrains is the correct word -constraining factors or constraints -for the study inclusion criteria -please specify what you mean by "levels of the HIV care continuum" -I see you have it below, please considering moving it up to the first time it is mentioned and/or explaining it in the introduction/background -I am unclear why the screening criteria are different by study type -please elaborate and/or make more similar -for example, shouldn't all studies, regardless of type, have overlapping criteria related to the HIV care continuum, gender diversity, social context, and contain some qualitative data? -again it looks like you have a quality assessment tool for mixed methods and non-research, but what about qualitative studies (such as the COREQ 32-item checklist) -with respect to the population (2.4.4), it is no longer convention to use the terminology "biological man" as it positions trans people as less than; the currently recognized terminology is "sex labeled at birth" for birth sex, and thereby "trans women are people who identify as female/woman or on the transfeminine spectrum but who were labeled male sex at birth -how will you account for social ecological differences across contexts (if taking into consideration a global perspective) Discussion -the discussion would benefit from expanded description of the implications of the study findings -to whom will the study be applicable, what will be the most significant contribution -more details about where it will be shared would also be helpful -what are some of the potential limitations of this study -this paper would benefit from editing support. There are several minor grammatical errors throughout that make the message less clear. I did not pick up on all of them, but one example was the line "nevertheless, the sheer low number of transgender people enrolled in outpatient care show a gap in HIV care engagement that need to be addressed" should read: "shows a gap In HIV care that needs to be addressed" Another example is in screening -"using the following f criteria" -what are f criteria? As has been clearly discussed by the authors, a combination of political change and major cuts have been affecting child and maternal health and increasing mortality. As always happens, vulnerable populations are deeply affected by such changes. Of course, child mortality does not necessarily have any link with management and care for transgender women but illustrates well how political problems and unfair allocation of funds may impact any population, especially those who are more vulnerable.
REVIEWER
The sentence on advances versus "a wave of resurging antihomosexuality laws and policies" seems very interesting, but should be rephrased: there is no verbal structure related to the interesting (although sad) concept of a conservative wave.
A second remark about this sentence refers to its strong Western, high-income countries bias, where I do agree advances and conservative reactions have been pushing such issues back and forth like a pendulum.
We should not forget that in several societies, values and mores have been rather "fossilized" in static structures, so there is no advances, nor reactions: things just stay where they have been for decades (sometimes centuries). There are several examples: from mass executions of people who use substances in countries such as Indonesia and the Philippines to the beating of gay couples in countries under the sharia (among a close to infinite series of terrible news, I´ve selected just a recent one as follows: https://www.independent.co.uk/news/world/asia/islamic-courtindonesia-gay-men-85-lashes-sex-caught-homosexuality-laws-firsttime-khairil-jamal-a7740626.html).
The authors' insights availale at p. 8/23, 1st para., are great, fostering a more nuanced perspective on issues that tend to be just "blended together", creating a false homogeneity.
Mesosystems should be rather defined as interactions between two or MORE microsystems or superimposed levels of interacting structures and determinants. Figure 1 .8 of the reference as follows graphically shows what I´m trying to say, just considering one will focus on slices of the overall picture: https://www.amazon.com/gp/product/0674436539/ref=ox_sc_sfl_titl e_9?ie=UTF8&psc=1&smid=ATVPDKIKX0DER
Data screening and extraction are very well described but lack a diagram that may be hypothetical, but notwithstanding illustrative. P. 5/23 -I do agree with everything the authors have written, but I think there is a missing piece here. I do agree that "causal structures change over time" and with the second statement highlighting the role of stakeholders, leverage points etc..., but I think structural determinants cannot be ignored (for instance political veto and budgetary contraints). Just as coincidence, immediately before I had opened BMJ Open site to perform this review, I read the post as follows in the BMJ homepage: https://www.bmj.com/content/362/bmj.k3583 As has been clearly discussed by the authors, a combination of political change and major cuts have been affecting child and maternal health and increasing mortality. As always happens, vulnerable populations are deeply affected by such changes. Of course, child mortality does not necessarily have any link with management and care for transgender women but illustrates well how political problems and unfair allocation of funds may impact any population, especially those who are more vulnerable. The sentence on advances versus "a wave of resurging antihomosexuality laws and policies" seems very interesting, but should be rephrased: there is no verbal structure related to the interesting (although sad) concept of a conservative wave.
The authors' insights availale at p. 8/23, 1st para., are great, fostering a more nuanced perspective on issues that tend to be just "blended together", creating a false homogeneity. Mesosystems should be rather defined as interactions between two or MORE microsystems or superimposed levels of interacting structures and determinants. Figure 1 . The studies that have both trans participants and other population groups (e.g., health workers, general population) may provide information to understand the interaction patterns between different system levels influencing transgender persons' engagement with HIV prevention and care programs, and thus should be included for synthesis in the review. Since our review is targeted among transgender people, only the data related to the transgender people's engagement with HIV care will be synthesized (Page 12, Paragraph 3) 1.3 I think there may be a typo -"apply in inclusion" should read "apply inclusion"?
Removed "in" ---see abstract 1.4 -you specify tools for mixed methods appraisal and text, opinion, and non-research studies -by text do you mean qualitative? If not, how will you assess quality of the qualitative studies (e.g., COREQ 32-item checklist). Please specify.
For clarity, we now corrected the phrase non-research studies as non-empirical studies. The quality of non-empirical studies, text (e.g., communication, correspondence) and opinion will be evaluated by using QARI critical appraisal tool (Page 12, Paragraph 1). The corrections have also been made in the abstract.
As far as the critical appraisal of qualitative studies, the mixed-methods appraisal tool would allow us to assess the quality for both quantitative and qualitative studies. For each quantitative or qualitative study included in the review, the MMAT provides a score that refers to the number of criteria met divided by four to calculate the percentage of the study quality. For a mixed-methods study, the overall quality score is the lowest percentage of either the qualitative method or the quantitative method.
The suggested COREQ statement is a reporting guidance for primary qualitative studies and not a critical appraisal tool. 1.5 -can you add a line at the end of methods and analysis about the implications of these study findings (e.g., why is this study important, who will the results be important for, what will they inform) Due to the strict word limit and prescribed structure, we cannot add a sentence in this part of the abstract, but revised the strengths and limitations of the study to reflect this point 1.6 -please add an example of the peerreviewed journal you will seek to publish in OR type of journal (e.g., LGBT health journal, HIV/AIDS journal) Due to the strict word limit and prescribed structure, we cannot add a sentence in this part of the abstract, but revised discussion part of the study to reflect this point 2 Strengths and limitations of the study -overall, these could be strengthened by highlighting the importance of the study that you are exploring (trans peoples' engagement in HIV care, not only the strength of using theory and your particular methodology) Revised phrase 'systematic and felt stigma' to 'enacted through forms of stigma and discrimination'. Moreover, concrete examples to describe these concepts are provided. ----see page 5 3.7 the last sentence isn't complete? Do you mean that resurging anti-homosexuality laws and policies that threaten LGBT populations' access to health services perpetuates stigma and discrimination? Is because of stigma and discrimination? Please clarify.
Deleted last sentence 3.8 it would be helpful to state that life chances are unequally structured and limit personal agency Added last sentence: 'In other words, life chances are unequally structured and limit personal agency in the context of healthcare access, treatment and medication.' ----see page 5 3.9 agency should be defined within the context of healthcare access Added last sentence: 'In other words, life chances are unequally structured and limit personal agency in the context of healthcare access, treatment and medication.' ----see page 5
3.10 -transwomen of colour should be trans women (with a space), similarly trans menplease change throughout Added space between 'trans woman' and 'trans man' thoughout 3.11 -if reflecting on structuring mechanisms of race, social class, age, HIV status, have the authors considered mentioning intersectionality theory explicitly, as they have references from intersectionality theorists?
Rephrased the sentence to explicitly emphasize the idea of intersectionality and inequalities: "Scoping the HIV care literature, the often sedimented intersections of risk are marked by social, political, cultural, and geographical axes of gender, sexuality, age, race or economic wealth inequalities [15] [16] [17] [18] [19] We imagined that keeping the inclusion criteria open for all kinds of studies would increase the volume (number) of studies to be included for synthesis in the review; and thus, one of our inclusion criteria is to limit the studies in terms of study design.
According to your comment, we have clarified the study inclusion and exclusion criteria on Page 11, Paragraph 1. 4.5 -with respect to the population (2.4.4), it is no longer convention to use the terminology "biological man" as it positions trans people as less than; the currently recognized terminology is "sex labeled at birth" for birth sex, and thereby "trans women are people who identify as female/woman or on the transfeminine spectrum but who were labeled male sex at birth Rephrased statements in 2.4.4 as "In this review project, transgender is defined as persons whose gender identity or expression is different from their sex labeled at birth (e.g., trans women are people who identify as female/woman or on the transfeminine spectrum but who were labeled male sex at birth).----see page 11 4.6 again it looks like you have a quality assessment tool for mixed methods and nonresearch, but what about qualitative studies (such as the COREQ 32-item checklist)
This comment is identical to comment 1.4. As we have mentioned in the response column and the text, the quality of qualitative studies will be evaluated by using Mixed-methods appraisal tool. The quality of opinion based and more descriptive papers will be evaluated using the JBI QARI assessment tool for opinion based research. 4.7 how will you account for social ecological differences across contexts (if taking into consideration a global perspective)
On page 17, we added the statements, "We also encourage authors to adapt or translate the framework in their local context and consider other relevant dimensions such as transgender subgroupings, cultural-specific facilitators and barriers to treatment adherence." 5 Discussion 5.1 -the discussion would benefit from expanded description of the implications of the study findings -to whom will the study be applicable, what will be the most significant contribution
The expanded description of the implications of the study findings has been added to the discussion section on Page 18.
5.2 -more details about where it will be shared would also be helpful
We already have a sub-heading for the dissemination (Page 18). The direct and indirect implications of the review findings have been mentioned in the discussion section. 5.3 -what are some of the potential limitations of this study 5.4 -this paper would benefit from editing support. There are several minor grammatical errors throughout that make the message less clear. I did not pick up on all of them, but one example was the line "nevertheless, the sheer low number of transgender people enrolled in outpatient care show a gap in HIV care engagement that need to be addressed" should read: "shows a gap In HIV care that needs to be addressed" Another example is in screening -"using the following f criteria" -what are f criteria?
The authors continuously revised and improved grammatical editing of manuscript. We also asked an external reader to help the authors finalized the manuscript. 2 The sentence on advances versus "a wave of resurging anti-homosexuality laws and policies" seems very interesting, but should be rephrased: there is no verbal structure related to the interesting (although sad) concept of a conservative wave.
We should not forget that in several societies, values and mores have been rather "fossilized" in static structures, so there is no advances, nor reactions: things just stay where they have been for decades (sometimes centuries). There are several examples: from mass executions of people who use substances in countries such as Indonesia and the Philippines to the beating of gay couples in countries under the sharia (among a close to infinite series of terrible news, I´ve selected just a recent one as follows: https://www.independent.co.uk/news/worl d/asia/islamic-court-indonesia-gay-men-85-lashes-sex-caught-homosexuality-laws-first-timekhairil-jamal-a7740626.html).
Rephrased sentence "a wave of resurging…" and provided concrete recent examples of felt and systematic stigma still faced by transgender populations ---see page 5. 
GENERAL COMMENTS
Thank you for the opportunity to re-review this manuscript. I see marked improvement and appreciate the authors' attentiveness to addressing my comments. This is a timely and important synthesis.
There is just one lingering issue I see. The title refers to this study as a qualitative synthesis. To this end, I understand including mixed methods and evaluation studies with qualitative data and qualitative studies. However, I am unclear why quantitative studies are being included and why their quality is being assessed. In the discussion, the study is then referred to as a realist review. The manuscript would benefit from a clearer description of the study design, and if qualitative evidence synthesis is maintained as the review type, I would suggest clarifying why/how quantitative studies are included. If they are included in a substantial way it may be considered a different type of review. There is just one lingering issue I see. The title refers to this study as a qualitative synthesis. To this end, I understand including mixed methods and evaluation studies with qualitative data and qualitative studies. However, I am unclear why quantitative studies are being included and why their quality is being assessed.
REVIEWER
The manuscript would benefit from a clearer description of the study design, and if qualitative evidence synthesis is maintained as the review type, I would suggest clarifying why/how quantitative studies are included. If they are included in a substantial way it may be considered a different type of review.
We agree with the reviewer that what should be included in the synthesis are mixed methods and evaluation studies with qualitative data and qualitative studies and we have rephrased the study inclusion section to clarify this (see page 10). For consistency, we adapted the original text of the abstract section to bring it in line with the reviewer's comment. Smaller adaptations were made throughout the protocol text to avoid confusion.
We provided more details on our choice for the MMAT critical appraisal instrument. In line with the changes made to the study inclusion section, we have rephrased the section (see page 11) on critical appraisal as follows:
